Titlebook: Neurological and Psychiatric Disorders; Frank I. Tarazi,John A. Schetz Book 2005 Humana Press 2005 Depression.Parkinson.Syndrom.attention.

高貴領(lǐng)導(dǎo)

inconceivable

Neural Principles of Neurological and Psychiatric Disordersle and serves as the foundation for in-depth preclinical research on neurological and psychiatric disorders. Most of the neurotransmitter receptors have been cloned and their anatomical localization and distribution have been clarified using advanced neurochemical methods. Novel discoveries have gre

ironic

Pharmacotherapeutic Principles of Neurological and Psychiatric Disordersransmission with drugs that intervene at chemical synapses. The receptors, transporters, and enzymes for the dopaminergic, serotonergic, and noradrenergic systems are the most common neuropsychiatric drug targets, because these neurotransmitter systems play a central role in the regulation of a rang

遺產(chǎn)

Alzheimer’s Disease death of neurons, in the limbic system and associated regions of the cerebral cortex. A major molecular alteration in AD is increased amyloidogenic processing of the amyloid precursor protein (APP) resulting in increased production and accumulation of amyloid b-peptide (Ab) in the brain. Ab may pro

泛濫

Intend

Parkinson’s Disease develop a slowly progressive and disabling disorder with motor, cognitive, and behavioral symptoms. It is well established that neurodegeneration in this disease affects mainly dopaminergic neurons in the basal ganglia, and recent progress in neuroscience research has begun to establish the pathoph

先行

舉止粗野的人

Autism Spectrum Disordersm disorders affect 60 out of 10,000 individuals, resulting in significant costs to families and society. Neuropathological and imaging studies point to abnormalities in the limbic system and the cerebellum, and accelerated brain grown in the first 2 years of life. Abnormalities in serotonin function

mortuary

Tourette’s Syndrome and Tic Disorders manifests in the first decade of life, and may be a considerable source of morbidity as it waxes and wanes. Advances in neuroscience, psychopharmacology, and psychotherapy are improving our understanding and the treatment of TS. Multimodal interventions that include focused treatment of comorbid co

Liability

Obsessive-Compulsive Disorderonducted over the past decade has provided much insight into the underlying neuropathology, allowing significant advances in the treatment of these patients. Whereas psychotherapy was previously the only mode of treatment for OCD, pharmacological agents and psychosurgical procedures are proving to b